Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.

Fig 1) Patient numbers by biologic treatment at inclusion
Last update: 17. November | total n= 28,188

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: 17. November | total n= 28,188

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1102 1709
Bimekizumab 546 0
Brodalumab 613 0
Certolizumab 256 0
Efalizumab 35 0
Etanercept 312 72
Golimumab 25 0
Guselkumab 2366 0
Infliximab 102 1
Ixekizumab 1190 0
Risankizumab 2464 0
Secukinumab 2334 0
Tildrakizumab 2052 0
Ustekinumab 786 84
Apremilast 819 0
Ciclosporin 402 0
Deucravacitinib 341 0
Fumaric acid esters 2694 0
Dimethyl fumarate 3590 0
Methotrexate 3926 0
Tofacitinib 2 0
Upadacitinib 9 0
other systemics 356 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: 17. November | total n= 28,188

 

Fig. 4) Rate of patients by type of registry site
Last update: 17. November | total n= 28,188

 

Fig. 5) Registered PsoBest centers
Last update: 17. November| n= 1,217 | updated monthly